Insurance continuity and human papillomavirus vaccine uptake in Oregon and California federally qualified health centers

American Journal of Public Health

Volumn 104, Issue 9, 2014, Pages

  Cowburn, Stuart ^a   Carlson, Matthew ^b   Lapidus, Jodi ^c   Heintzman, John ^c   Bailey, Steffani ^c   DeVoe, Jennifer ^c  

^a OCHIN Inc   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; ELECTRONIC MEDICAL RECORD; ETHNOLOGY; FEMALE; HEALTH INSURANCE; HUMAN; INSURANCE; PATIENT ATTITUDE; RETROSPECTIVE STUDY; SAFETY NET HOSPITAL; SOCIOECONOMICS; STATISTICS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CALIFORNIA; CHILD; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; OREGON; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; SAFETY-NET PROVIDERS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84906084960     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.302007     Document Type: Article

References (47)

1. National Institutes of Health National Cancer Institute. SEER Stat Fact Sheets: Cervix Uteri. 2012. Available at: http://seer.cancer.gov/statfacts/html/ cervix.html#incidence-mortality. Accessed May 9, 2012.
2. Zhou J, Enewold L, Peoples GE, et al. Trends in cancer screening among Hispanic and White non-Hispanic women, 2000-2005. J Womens Health (Larchmt). 2010;19(12):2167-2174.
3. National Institutes of Health National Cancer Institute. Cancer Health Disparities Fact Sheet. 2008. Available at: http://www.cancer.gov/cancertopics/ factsheet/disparities/cancer-health-disparities. Accessed September 5, 2012.
4. Freeman HP, Wingrove BK. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005. NIH Pub. No. 05-5282.
5. Vesco KK, Whitlock EP, Eder M, et al. Screening for Cervical Cancer: A Systematic Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 86. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ Pub. No. 11-05156-EF-1.
6. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57(1):7-28.
7. Schiffman M, Castle P, Jeronimo J. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
8. National Association of Community Health Centers. America's Health Centers. 2011. Available at: http:// www.nachc.com/client//America'sCHCsFS.pdf. Accessed December 1, 2013.
9. Tiro JA, Pruitt SL, Bruce CM, et al. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012;30(13):2368-2375.
10. Gold R, Naleway AL, Jenkins LL, et al. Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon. Prev Med. 2011;52(6):456-458.
11. Federico SG, Abrams L, Everhart RM, Melinkovich P, Hambidge SJ. Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery. Am J Public Health. 2010;100(9):1630-1634.
12. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60 (RR02):1-64.
13. Probst JC, Wang J-Y, Moore CG, Powell MP, Martin AB. Continuity of health insurance coverage and perceived health at age 40. Med Care Res Rev. 2008;65 (4):450-477.
14. Klein K, Glied S, Ferry D. Entrances and Exits: Health Insurance Churning, 1998-2000. Commonwealth Fund. 2005. Available at: http://www. commonwealthfund.org/Content/Publications/Issue-Briefs/2005/Sep/ Entrances-And-Exits-Health-Insurance-Churning-1998-2000.aspx. Accessed May 9, 2012.
15. Schoen C, DesRoches C. Uninsured and unstably insured: the importance of continuous insurance coverage. Health Serv Res. 2000;35(1 Pt 2):187-206.
16. Gold R, DeVoe JE, Shah A, Chauvie S. Insurance continuity and receipt of diabetes preventive care in a network of federally qualified health centers. Med Care. 2009;47(4):431-439.
17. Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010;47(6):596-599.
18. Staras SAS, Vadaparampil ST, Haderxhanaj LT, Shenkman EA. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008. J Adolesc Health. 2010;47(4):381-388.
19. Gold R, DeVoe JE, McIntire PJ, Puro JE, Chauvie SL, Shah AR. Receipt of diabetes preventive care among safety net patients associated with differing levels of insurance coverage. J Am Board Fam Med. 2012;25 (1):42-49.
20. Cowburn S, Carlson MJ, Lapidus JA, DeVoe JE. The association between insurance status and cervical cancer screening in community health centers: exploring the potential of electronic health records for population-level surveillance, 2008-2010. Prev Chronic Dis. 2013;10: E173.
21. Centers for Disease Control and Prevention. VFC Detailed Questions and Answers for Parents. 2012. Available at: http://www.cdc.gov/vaccines/programs/ vfc/parents/qa-detailed.html. Accessed May 9, 2012.
22. Devoe JE, Gold R, Spofford M, et al. Developing a network of community health centers with a common electronic health record: description of the Safety Net West Practice-based Research Network (SNW-PBRN). J Am Board Fam Med. 2011;24(5):597-604.
23. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2011;127(1):77-84.
24. Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine. 2011;29(3):528-534.
25. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):989-995.
26. Schluterman NH, Terplan MS, Lydecker AD, Tracy JK. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011;29 (21):3767-3772.
27. Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546-3556.
28. Etter DJ, Zimet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol. 2012;24(5):305-310.
29. Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med. 2008;65 (7):501-506.
30. Brown H, Prescott R. Applied Mixed Models in Medicine. 2nd ed. Chichester, NY: John Wiley &Sons; 2006:476.
31. Larsen K, Merlo J. Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol. 2005;161(1):81-88.
32. Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med. 2012;42 (1):44-52.
33. Reiter PL, Brewer NT, Gottlieb SL, McRee A-L, Smith JS. How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen. Vaccine. 2009;27(49):6840-6844.
34. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health. 2010;35(6):645-652.
35. Pruitt SL, Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med. 2010;38(5):525-533.
36. Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev. Med. 2011;52 (5):398-400.
37. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168(1):76-82.
38. US Department of Health and Human Services. Young Adults and the Affordable Care Act. Available at: http://www.healthcare.gov/news/factsheets/ 2011/08/ young-Adults.html. Accessed December 27, 2012.
39. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(34):685-693.
40. Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep. 2013;62(29):591-595.
41. Darden PM, Thompson DM, Roberts JR, et al. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics. 2013;131(4):645-651.
42. Bastani R, Glenn B, Tsui J. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1463-1472.
43. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171(3):357-367.
44. Liddon NC, Hood JE, Leichliter JS. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth. Vaccine. 2012;30(16):2676-2682.
45. Devoe JE, Gold R, McIntire P, Puro J, Chauvie S, Gallia CA. Electronic health records vs Medicaid claims: completeness of diabetes preventive care data in community health centers. Ann Fam Med. 2011;9(4):351-358.
46. Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48(5):426-431.
47. Ferris DG, Waller JL, Owen A, Smith J. HPV vaccine acceptance among mid-Adult women. J Am Board Fam Med. 2008;21(1):31-37.